Quarterly report pursuant to Section 13 or 15(d)

Mezzanine Equity (Details)

v3.23.2
Mezzanine Equity (Details) - Series S Convertible Preferred Stock
$ in Millions
Dec. 28, 2022
USD ($)
shares
Jul. 01, 2023
shares
Dec. 31, 2022
shares
Mezzanine Equity [Line Items]      
Preferred stock, conversion ratio   1  
Convertible preferred stock, shares outstanding (in shares)   100,000 100,000
Soin Therapeutics      
Mezzanine Equity [Line Items]      
Potential value | $ $ 30    
Company tendered (in shares) 100,000